Other Clinical Trial - Substance Misuse To Psychosis for Stimulants

Status Recruiting

Clinical Trial Summary

In Hong Kong, less than 5% of stimulants abusers were reported to misuse these substances via injection. Also, it is well known that patients with co-morbid substance abuse/dependence and psychosis or schizophrenia-related disorders are prone to earlier treatment discontinuation and high oral medication non-adherence, resulting in poorer overall outcomes. With the recent availabilities of the 4-weekly long-acting injectable form of aripiprazole, and the 4-weekly and the 3-monthly long-acting injectable form of paliperidone palmitate, on the background of the surging phenomenon of stimulant misuses in Hong Kong, it is a timely opportunity to conduct an early pharmacotherapy intervention study to offer an evidence-based strategy aiming to stop individuals with substance use disorders with psychosis to develop into a more chronic disabling dependence or co-morbid state.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Mental Disorders
Pharmacotherapy
Psychotic Disorders
Schizophrenia
Schizophrenia and Related Disorders
Stimulant Abuse
Stimulant Dependence
Stimulant Use With Stimulant-Induced Psychotic Disorder (Diagnosis)

Clinical Trial Details

NCT number	NCT03485417
Study type	Interventional
Source	The University of Hong Kong
Contact	albert KK Chung, Dr
Phone	+85222553060
Email	chungkka@hku.hk
Status	Recruiting
Phase	Phase 2/Phase 3
Start date	June 1, 2019
Completion date	May 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05083377` - Clozapine Use Pattern in the Province of Seville
Recruiting	`NCT06313918` - Exercise Therapy in Mental Disorders-study	N/A
Recruiting	`NCT06134661` - Accelerated rTMS for Psychomotor Slowing	N/A
Completed	`NCT01433094` - Study on Psychoeducation Enhancing Results of Adherence in Schizophrenia	N/A
Terminated	`NCT05526833` - An Extension Protocol for Patients Who Previously Completed the TMS Pilot Study	N/A
Recruiting	`NCT05982158` - Avatar-mediated Therapy Versus Cognitive Behavioural Therapy for Persisting Experiences of Hearing Voices	N/A
Active, not recruiting	`NCT06175559` - Embedded Narrative in Interactive Game Design for Improving Medication Adherence of Schizophrenia	N/A
Active, not recruiting	`NCT05673941` - "InMotion" - Physical Training With Creative Movement as an Intervention for Adults With Schizophrenia	N/A
Recruiting	`NCT02916810` - TMS for Symptom Reduction in Schizophrenia	N/A
Recruiting	`NCT05958875` - The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.	Phase 4
Recruiting	`NCT03525054` - Semantic and Syntactic Computerized Analysis of Free Speech
Recruiting	`NCT05389345` - tDCS and Executive Function Training for Schizophrenia	N/A
Completed	`NCT05601050` - Linguistic Predictors of Outcomes in Psychosis
Completed	`NCT03075202` - Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia
Completed	`NCT03921450` - Overcoming Psychomotor Slowing in Psychosis (OCoPS-P)	N/A
Completed	`NCT06231407` - Increasing Medication Check Participation Through Applying CT-r	N/A
Recruiting	`NCT04478838` - "Extended" (Alternate Day) Antipsychotic Dosing	Phase 4
Completed	`NCT04366401` - Efficacy of Prebiotic and Probiotic Dietary Modulation in Schizophrenic Disorders	N/A
Completed	`NCT04612777` - A Trial of "Opening Doors to Recovery" for Persons With Serious Mental Illnesses	N/A
Not yet recruiting	`NCT06191965` - MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction	Phase 2/Phase 3